Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Eye drop delivery of pigment epithelium-derived factor-34 promotes retinal ganglion cell neuroprotection and axon regeneration.

Vigneswara, Vasanthy, Esmaeili, Maryam, Deer, Louise, Berry, Martin, Logan, Ann and Ahmed, Zubair 2015. Eye drop delivery of pigment epithelium-derived factor-34 promotes retinal ganglion cell neuroprotection and axon regeneration. Molecular and Cellular Neuroscience 68 , pp. 212-221. 10.1016/j.mcn.2015.08.001

[thumbnail of main.pdf] PDF - Published Version
Available under License Creative Commons Attribution.

Download (1MB)

Abstract

Axotomised retinal ganglion cells (RGCs) die rapidly by apoptosis and fail to regenerate because of the limited availability of neurotrophic factors and a lack of axogenic stimuli. However, we have recently showed that pigment epithelium-derived factor (PEDF) promotes RGC survival and axon regeneration after optic nerve crush injury. PEDF has multiple fragments of the native peptide that are neuroprotective, anti-angiogenic and anti-inflammatory. Here we investigated the neuroprotective and axogenic properties of a fragment of PEDF, PEDF-34, in retinal neurons in vitro and when delivered by intravitreal injection and eye drops in vivo. We found that PEDF-34 was 43% more neuroprotective and 52% more neuritogenic than PEDF-44 in vitro. Moreover, in vivo, intravitreal delivery of 1.88nM PEDF-34 was 71% RGC neuroprotective at 21days after optic nerve crush compared to intact controls, whilst daily eye drops containing 1.88nM PEDF-34 promoted 87% RGC survival. After topical eye drop delivery, PEDF-34 was detected in the vitreous body within 30min and attained physiologically relevant concentrations in the retina by 4h peaking at 1.4±0.05nM by 14days. In eye drop- compared to intravitreal-treated PEDF-34 animals, 55% more RGC axons regenerated 250μm beyond the optic nerve lesion. We conclude that daily topical eye drop application of PEDF-34 is superior to weekly intravitreal injections in promoting RGC survival and axon regeneration through both direct effects on retinal neurons and indirect effects on other retinal cells.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Schools > Optometry and Vision Sciences
Publisher: Elsevier
ISSN: 1044-7431
Date of First Compliant Deposit: 4 July 2025
Date of Acceptance: 3 August 2015
Last Modified: 04 Jul 2025 13:00
URI: https://orca.cardiff.ac.uk/id/eprint/179502

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics